Campus Bio-Medico
Rome, 00128, Italy
NCT Number: NCT02198547
The aim of the study is to evaluate if Magnesium added to ropivacaine can reduce onset time and can enhance offset time.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Rome, 00128, Italy
Patients are randomly divided into two groups: group "M" (Ropivacaina 7,5 mg/ml with Mg 4 mg/Kg)and group"C" (without Mg).
Standard monitoring is applied to each patient in perioperative period. An indipendent observer collect data: time to perform block, sensitivity onset,motor onset, pain during surgery and complication.
In the post-operative period till 24 hours for each patient is evaluated off-set time, pain and analgesic consumption.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mg used with ropivacaine for sciatic nerve blick
Ropivacaine 7,5 mg/ml used for sciatic nerve block
Time frame: Till 24 hours
We evaluate if Mg affects onset and offset time of ropivacaine 7,5 mg/ml in sciatic block at popliteal level
Time frame: 3 hours
We evaluate post-operative pain at rest and in movement at 3-6-12-24 hours with NRS scale
Time frame: till 24 hours
We evaluate consumption of opioid and non-opioid analgesic used in the post-operative period.
Time frame: 6 hours
Evaluation of pain with NRS scale
Time frame: 12 hours
Evaluation of pain with NRS scale
Time frame: 24 hours
Evaluation of pain with NRS scale
Time frame: At 24 hours
We evaluate the grade of approval of patients with a questionnaire
Campus Bio-Medico University
Other
Evaluation of Magnesium as Adjuvant to Ropivacaine for Sciatic Block at Popliteal Level.
Acronym: Mg
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07052721
Ankle Arthropathy, Clavicle Fracture
La Jolla, California, United States
View Trial DetailsNCT05101499
Akin Osteotomy, Foot Deformities
Paris, IDF, France
View Trial DetailsNCT02984462
Foot Deformities, Hallux Valgus
Bordeaux, France
View Trial DetailsNCT07589829
Foot Deformities, Hallux Valgus
Kayseri, Kocasinan, Turkey (Türkiye)
View Trial Details